Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)

Abstract Vascular-targeted drug delivery systems could provide more efficient and effective pharmaceutical interventions for treating a variety of diseases including cardiovascular, pulmonary, inflammatory, and malignant disorders. However, several factors must be taken into account when designing these systems. The diverse blood hemodynamics and rheology, and the natural clearance process that tend to decrease the circulation time of foreign particles all lessen the probability of successful carrier interaction with the vascular wall. An effective vascular-targeted drug delivery system must be able to navigate through the bloodstream while avoiding immune clearance, attach to the vascular wall, and release its therapeutic cargo at the intended location. This review will summarize and analyze current literature reporting on (1) nanocarrier fabrication methods and materials that allow for optimum therapeutic encapsulation, protection, and release; (2) localization and binding dynamics of nanocarriers as influenced by hemodynamics and blood rheology in medium-to-large vessels; (3) blood cells' responses to various types of nanocarrier compositions and its effects on particle circulation time; and (4) properties that affect nanocarrier internalization at the target site.

[1]  J. Milbrandt,et al.  Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. , 2010, Biomaterials.

[2]  Martin Holzer,et al.  Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. , 2010, Toxicology.

[3]  Jun Li,et al.  Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[4]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Matthew D. McDermott,et al.  The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Phapanin Charoenphol,et al.  Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.

[7]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[8]  J. Błasiak,et al.  How to study dendriplexes II: Transfection and cytotoxicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Robert Langer,et al.  Spatiotemporal controlled delivery of nanoparticles to injured vasculature , 2010, Proceedings of the National Academy of Sciences.

[10]  Yunhui Liu,et al.  Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro , 2010, Cellular and Molecular Neurobiology.

[11]  Sei-Young Lee,et al.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.

[12]  Chen Jiang,et al.  Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.

[13]  Jeffery Gaspard,et al.  Polymerization of hydrogels inside self-assembled block copolymer vesicles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[14]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[15]  Ramanathan Vaidyanathan,et al.  Antiangiogenic properties of silver nanoparticles. , 2009, Biomaterials.

[16]  O. Eniola-Adefeso,et al.  Fabrication of biodegradable spheroidal microparticles for drug delivery applications. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Rekha Srinivasan,et al.  In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes. , 2009, Journal of biomedical materials research. Part A.

[18]  R. Razavi,et al.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[19]  L. Traub Tickets to ride: selecting cargo for clathrin-regulated internalization , 2009, Nature Reviews Molecular Cell Biology.

[20]  Mauro Ferrari,et al.  Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.

[21]  D. Matei,et al.  Pegylated liposomal doxorubicin in ovarian cancer , 2009, Therapeutics and clinical risk management.

[22]  J. Maessen,et al.  The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. , 2009, Biomaterials.

[23]  Vesa-Pekka Lehto,et al.  In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Yoshiro Kaneko,et al.  Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. , 2009, Biomacromolecules.

[25]  L. Jennings Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis , 2009, Thrombosis and Haemostasis.

[26]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Kristopher J. Koudelka,et al.  Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection , 2009, Journal of Neuroimmunology.

[28]  Erkki Ruoslahti,et al.  Targeting atherosclerosis by using modular, multifunctional micelles , 2009, Proceedings of the National Academy of Sciences.

[29]  C Jeffrey Brinker,et al.  Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.

[30]  D. Discher,et al.  Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase. , 2009, Biomacromolecules.

[31]  J. Panyam,et al.  Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Tanmay Bera,et al.  Characterization of antiplatelet properties of silver nanoparticles. , 2009, ACS nano.

[33]  Mauro Ferrari,et al.  The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.

[34]  Gary Siuzdak,et al.  Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin , 2009, PLoS pathogens.

[35]  Yu Xiao,et al.  Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo. , 2009, Cancer biotherapy & radiopharmaceuticals.

[36]  Eleonore Fröhlich,et al.  The role of nanoparticle size in hemocompatibility. , 2009, Toxicology.

[37]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[38]  V. Wiwanitkit,et al.  Gold nanoparticles and a microscopic view of platelets: a preliminary observation. , 2009, Cardiovascular journal of Africa.

[39]  Kitae E. Park,et al.  Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. , 2009, Molecular pharmaceutics.

[40]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[41]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[42]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[43]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[44]  W. Freeman,et al.  Porous silicon in drug delivery devices and materials. , 2008, Advanced drug delivery reviews.

[45]  Mauro Ferrari,et al.  The margination propensity of spherical particles for vascular targeting in the microcirculation , 2008, Journal of nanobiotechnology.

[46]  Baowei Fei,et al.  Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.

[47]  Riyi Shi,et al.  Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. , 2008, Nanomedicine.

[48]  E. Simanek,et al.  The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. , 2008, Molecular pharmaceutics.

[49]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[51]  Samuel A Wickline,et al.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.

[52]  H. Dai,et al.  Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. , 2008, Journal of the American Chemical Society.

[53]  Milan Makale,et al.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.

[54]  P. Buehler,et al.  Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. , 2008, Antioxidants & redox signaling.

[55]  D. Wagner,et al.  The vessel wall and its interactions. , 2008, Blood.

[56]  Luisa Pedro,et al.  Purification of Bionanoparticles , 2008, Chemical engineering & technology.

[57]  M. Eid,et al.  In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[58]  A. Nemmar,et al.  The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats , 2008, Experimental biology and medicine.

[59]  G. Bendas,et al.  VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.

[60]  Noriaki Ohuchi,et al.  Presidential symposium : Individualized diagnosis for tailored treatment of breast cancer In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine , 2008 .

[61]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[62]  J. Salonen,et al.  Mesoporous silicon in drug delivery applications. , 2008, Journal of pharmaceutical sciences.

[63]  M. Ferrari,et al.  Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2008 .

[64]  N. M. Khazenzon,et al.  Nanoconjugate based on polymalic acid for tumor targeting. , 2008, Chemico-biological interactions.

[65]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[66]  Simon Benita,et al.  Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.

[67]  P. Hildgen,et al.  Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. , 2008, Molecular pharmaceutics.

[68]  A. Paillard,et al.  Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. , 2007, International journal of pharmaceutics.

[69]  J. Emmerich,et al.  Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. , 2007, Biomaterials.

[70]  Ji Guo,et al.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[71]  Jie Xue,et al.  Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. , 2007, Bioconjugate chemistry.

[72]  P. Swaan,et al.  Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.

[73]  S. Mitragotri,et al.  Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.

[74]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[75]  James R Baker,et al.  Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. , 2007, Small.

[76]  M. Ferrari,et al.  Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2007, Biomedical microdevices.

[77]  G. Kenner,et al.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.

[78]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[79]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[80]  Charles P. Lin,et al.  Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal Antibody , 2007, Pharmaceutical Research.

[81]  María J Alonso,et al.  Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). , 2007, Biomaterials.

[82]  R. Jugdaohsingh,et al.  Silicon and bone health. , 2007, The journal of nutrition, health & aging.

[83]  A. Zimmer,et al.  Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[84]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[85]  R. Eritja,et al.  Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. , 2007, Chemistry.

[86]  S. Hsu,et al.  Biocompatibility of poly(ether)urethane-gold nanocomposites. , 2006, Journal of biomedical materials research. Part A.

[87]  W. Lu,et al.  Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. , 2006, Cancer research.

[88]  P. Singh,et al.  Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. , 2006, Advanced drug delivery reviews.

[89]  Raoul Kopelman,et al.  Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.

[90]  T. Dutta,et al.  Investigations on the toxicological profile of functionalized fifth‐generation poly(propylene imine) dendrimer , 2006, The Journal of pharmacy and pharmacology.

[91]  L. Wågberg,et al.  The adsorption of hyperbranched polymers on silicon oxide surfaces. , 2006, Journal of colloid and interface science.

[92]  R. Stan Endocytosis pathways in endothelium: how many? , 2006, American journal of physiology. Lung cellular and molecular physiology.

[93]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Wadih Arap,et al.  Vascular Targeting: Recent Advances and Therapeutic Perspectives , 2006, Trends in Cardiovascular Medicine.

[95]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[96]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[97]  D. Hammer,et al.  I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. , 2005, Biophysical journal.

[98]  M. Kirkham,et al.  Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. , 2005, Biochimica et biophysica acta.

[99]  K. Claffey,et al.  Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature , 2005, Molecular Cancer Therapeutics.

[100]  M. Conese,et al.  Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[101]  J. Oh,et al.  Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles , 2005, Pharmaceutical Research.

[102]  M. Simionescu,et al.  Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery , 2005, Pharmaceutical Research.

[103]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[104]  Mansoor Amiji,et al.  Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies , 2005, Pharmaceutical Research.

[105]  W. Lu,et al.  Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. , 2005, International journal of pharmaceutics.

[106]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[107]  D. Muruve,et al.  The induction of inflammation by adenovirus vectors used for gene therapy. , 2005, Frontiers in bioscience : a journal and virtual library.

[108]  H. El-Shall,et al.  Interaction of PLGA nanoparticles with human blood constituents. , 2005, Colloids and surfaces. B, Biointerfaces.

[109]  V. Muzykantov,et al.  ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. , 2005, Blood.

[110]  M. Markman,et al.  Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies. , 2004, Gynecologic oncology.

[111]  M. Bryszewska,et al.  Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.

[112]  Shmuel Einav,et al.  Dynamics of Blood Flow and Platelet Transport in Pathological Vessels , 2004, Annals of the New York Academy of Sciences.

[113]  C James Kirkpatrick,et al.  Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation , 2004, Journal of materials science. Materials in medicine.

[114]  Aliasger K Salem,et al.  Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[116]  F. Bates,et al.  Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[117]  G. Nash,et al.  Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes. , 2003, American journal of physiology. Heart and circulatory physiology.

[118]  E. Namork,et al.  HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. , 2003, FEMS immunology and medical microbiology.

[119]  Rakesh K Jain,et al.  Red blood cells augment leukocyte rolling in a virtual blood vessel. , 2002, Biophysical journal.

[120]  A. Hoffman,et al.  A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex. , 2002, Bioconjugate chemistry.

[121]  D. Hammer,et al.  Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. , 2002, Biomaterials.

[122]  A. Hoffman,et al.  pH-sensitive polymers that enhance intracellular drug delivery in vivo. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[123]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[124]  G. Molema,et al.  Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs , 2001 .

[125]  G. Hoffman,et al.  Inflammatory Diseases of Blood Vessels , 2001 .

[126]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[127]  D Guthrie,et al.  Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  V. Muzykantov Targeting of superoxide dismutase and catalase to vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[129]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[130]  M J Pearson,et al.  Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery. , 2000, American journal of physiology. Heart and circulatory physiology.

[131]  G. Garcı́a-Cardeña,et al.  Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a , 2000, Annals of the New York Academy of Sciences.

[132]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[133]  L. Fenart,et al.  Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.

[134]  D. Hammer,et al.  Polymersomes: tough vesicles made from diblock copolymers. , 1999, Science.

[135]  D. McPherson,et al.  In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. , 1999, Journal of the American College of Cardiology.

[136]  R K Jain,et al.  Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. , 1996, Biophysical journal.

[137]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[138]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Y. Ohtsuka,et al.  Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles. , 1989, Biomaterials.

[140]  R M Heethaar,et al.  Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. , 1988, Arteriosclerosis.

[141]  F. Millero,et al.  Conditions for the occurrence of large near-wall excesses of small particles during blood flow. , 1988, Microvascular research.

[142]  H. Movat,et al.  PLATELET PHAGOCYTOSIS AND AGGREGATION , 1965, The Journal of cell biology.

[143]  J. Lahann,et al.  Multicompartmental microcylinders. , 2009, Angewandte Chemie.

[144]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[145]  Na Zhang,et al.  PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. , 2008, Bioconjugate chemistry.

[146]  V. Muzykantov,et al.  Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.

[147]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[148]  V. Muzykantov,et al.  Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. , 2008, Biomaterials.

[149]  P. Bagchi,et al.  Hydrodynamic interaction between erythrocytes and leukocytes affects rheology of blood in microvessels. , 2007, Biorheology.

[150]  R. Schwendener Liposomes in biology and medicine. , 2007, Advances in experimental medicine and biology.

[151]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[152]  Hong-Zhuan Chen,et al.  In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[153]  B. Pogue,et al.  Vascular and cellular targeting for photodynamic therapy. , 2006, Critical reviews in eukaryotic gene expression.

[154]  Shelton D Caruthers,et al.  Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[155]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[156]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[157]  P. Seth,et al.  The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. , 2002, Human gene therapy.

[158]  G. Ginsburg,et al.  Atherosclerosis and cancer: common molecular pathways of disease development and progression. , 2001, Annals of the New York Academy of Sciences.

[159]  C Baquey,et al.  In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging. , 1994, Clinical materials.